Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tamper-Resistant Pseudoephedrine Sparks Pharmacies’ Interest

This article was originally published in The Tan Sheet

Executive Summary

Ohio and West Virginia chain Fruth Pharmacy begins replacing the 30 mg PSE products available in its stores with Acura Pharmaceuticals’ Nexafed product. Meanwhile, DEA says Westport Pharmaceuticals should not make an extraction-proof claim for its Zephrex-D PSE product.

Advertisement

Related Content

Zephrex-D Solo Show In W.Va. Could Move Tamper-Resistant PSE To Starring Role
Zephrex-D Solo Show In W.Va. Could Move Tamper-Resistant PSE To Starring Role
Nexafed Gains Rite Aid Sales, But Stumbles In Extraction-Proof PSE Tests
In Challenging Opioid Market, Acura Still Seeks A Partner
Zephrex-D, Nexafed Make Marketing Pitch As Meth-Fighting Decongestants
Zephrex-D, Nexafed Make Marketing Pitch As Meth-Fighting Decongestants
In Brief
Rx-Only Pseudoephedrine Stalls As Meth Solution In Tennessee, Indiana
Acura To Launch Nexafed PSE Despite Limits Of Extraction Resistance
Pseudoephedrine Will Be Behind The Counter Across The Country By October

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106449

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel